Erasca, Inc. Common Stock (ERAS)

Health Care·equity

$16.03

+3.69% today

Extended hours $15.50

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

52/ 100

Score level

Average

5 of 6 checks had data

How it compares with the broader market is one of its highest-scoring factors, with business numbers score is below the middle.

ERAS scores higher than 72% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Erasca, Inc. Common Stock (ERAS) scores 52 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 1.56× 30-day average
52-week range: 2.10 – 24.28
Market cap: $5.17B
Earnings date: 10 Nov 2026

Volume: 7,771,553
Avg. volume (30d): 4,982,915

Open: 15.42
Previous close: 15.46
Day's range (regular session): 15.21 – 16.20

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.66
P/E (TTM): —
EPS (TTM): -0.95

Score breakdown · six named factors

Price trend

Strength vs the market

100

Company finances

Insider trades

—

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about ERAS right now

Erasca, Inc. Common Stock (ERAS) currently scores 52/100 on the Market Census six-factor composite, at the Average score level. ERAS is +3.69% on the day and +7.90% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in ERAS's data roughly balance out right now. ERAS's strongest factor is strength vs the market at 100/100 — a very strong read on how ERAS has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See ERAS in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score